AR and posterior cortical atrophy: For the first time, we revealed the therapeutic potential of nanomolar FL3 in 4 PCa cell lines, ADPC cell line LNCaP with full-length AR (AR-FL), CRPC cell line C4-2B with AR-FL, CRPC cell line 22Rv1 with AR-V7, and AR−CRPC cell line PC-3 [6, 73].